SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wesley0428 who wrote (572)2/18/1998 6:25:00 PM
From: John McCarthy   of 849
 
Wesley -

Thanks much for the info.

With respect to the Colon stuff:

1 - We have $11.0 mil. in Cash right now.

2 - We use up $2.0 mil. a Qtr.

Note:The $2.0 excludes any serious clinical money
for breast/prostate clinical stuff.

3 - If the Colon kit doesn't ship until late 3rd/early 4th
qtr. our cash position vs. our needs is going to be
a bit tacky but we should be Okay.

$11.0 - $6.0 = $5.0 (and we still have to finance the
inventory build on the colon stuff)

+ pay for the breast/prostate incremental clinical costs.

4 - I concede to Bill, but only this far:

98 Bladder Sales = $1.6 mil. (Recall I had said $ -0-)

of which we only collect $1.2 mil. in 98.

These monies are an add back to our cash level.

5 - Just wish we had more sales.

Regards,

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News